22 January 2026 in Journal of Integrative Neuroscience
Background: The perineuronal net (PNN) is an important extracellular environment around parvalbumin interneuron (PV IN) in the spinal cord. Chondroitin sulfate proteoglycan (CSPG) serves as a key factor mediating PNN effects on the spinal cord, primarily formed by covalently linked chondroitin sulfate glycosaminoglycan (CS-GAG) chains and diverse core proteins. Extensive research suggests that degradation of CS-GAG following nerve injury may contribute to severe spinal cord damage. Inhibiting CS-GAG degradation could enhance PNN stability and plasticity, thereby promoting recovery from nerve injury. Electroacupuncture (EA) intervention demonstrates significant neuroprotective effects, facilitating restoration of spinal cord nerve function and axonal regeneration. This study aims to observe the changes in CS-GAG and the expression of PV IN after spinal cord injury (SCI) in rats and explore the effect. Methods: An SCI model was established in Sprague–Dawley rats using an Infinite Horizon (IH) impactor, and EA was applied to the Jia-ji acupoints (EX-B2). The Basso–Beattie–Bresnahan (BBB) score of SCI rats was evaluated, and electromyography (EMG) of the gastrocnemius muscle of the hind limbs was performed. The protein expression levels of CS-GAG and glutamic acid decarboxylase (GAD) were detected using western blotting, and perineuronal nets (PNN) and PV IN were observed using immunofluorescence (IF). Fiber-optic calcium imaging was used to detect and analyze PV IN activity. Adeno-associated virus containing carbohydrate sulfotransferase 11 (Chst11) was injected into T9 and T10 spinal cord spaces using a microneedle, and changes in CS-GAG in the spinal cord of SCI rats before and after EA intervention were observed. Results: CS-GAG and GAD expression levels were significantly decreased after SCI and PNN stability was reduced. Chondroitinase ABC (ChABC) treatment increased PV IN activity and GAD expression. EA effectively promoted an increase in CS-GAG and GAD, improved PNN stability and PV IN activity, and reversed the inhibitory effect of Chst11, thereby facilitating the rehabilitation of rats with SCI. Conclusion: The mechanisms and effects of EA on SCI repair were investigated. The results revealed that EA can regulate the recovery of PNN structure and function via CS-GAG and GAD, improve PV IN activity, and reverse the inhibitory effect of Chst11 to promote SCI rehabilitation in rats.
26 March 2025 in Biomolecules and Biomedicine
Spinal cord injury (SCI) induces profound systemic changes, including disruptions in gut microbiome composition and host metabolism. This study aimed to investigate the impact of SCI on gut microbial diversity and serum metabolites in rats, and to explore potential microbiome–metabolite interactions that may influence recovery. Male Sprague–Dawley (SD) rats were assigned to either SCI or sham-operated groups. Fecal samples were collected for whole-genome metagenomic sequencing, and serum samples were analyzed using untargeted metabolomics. Gut microbial composition and diversity were assessed using α- and β-diversity indices, while Linear discriminant analysis effect size (LEfSe) identified differentially abundant taxa. Metabolomic pathway analysis was performed to detect significant changes in serum metabolites, and Spearman’s correlation was used to evaluate associations between gut microbes and metabolites. SCI significantly altered gut microbiota composition, with increased proportions of Ligilactobacillus and Staphylococcus, and decreased proportions of Lactobacillus and Limosilactobacillus. Metabolomic analysis revealed disrupted energy metabolism and elevated oxidative stress in SCI rats, as indicated by increased serum levels of pyruvate and lactic acid. Correlation analysis further identified significant associations between specific gut bacteria and key metabolites, suggesting microbiome-driven metabolic dysregulation following SCI. These findings highlight significant interactions between the gut microbiota and host metabolism after SCI and suggest that microbiome-targeted interventions may hold therapeutic potential for improving recovery by modulating metabolic function and oxidative stress responses.
1 January 2026 in Neural Plasticity
Background: Depression is one of the most common mental health conditions worldwide. Numerous studies have identified various factors associated with the onset of depression. Among these factors, inflammation is a key contributor. During the inflammatory process, pro‐inflammatory cytokines activate indole‐2,3‐dioxygenase (IDO), which converts tryptophan (TRP) to kynurenine (KYN) via the KYN pathway (KP). This increases the production of neurotoxic byproducts, thereby exacerbating depressive symptoms. Studies have shown that electroacupuncture (EA) has anti‐inflammatory and antidepressant properties. The present study aimed to investigate the effects of EA on depression and its mechanisms of action via IDO1 and the KP. Methods: An inflammation‐induced depression mouse model was created by injecting lipopolysaccharide (LPS) intraperitoneally. After the model was successfully established, the Hegu (L14) and Taichong (LR3) acupoints were treated with EA at a frequency of 15 Hz and an intensity of 0.3 mA for 45 min. A subset of mice received ketamine as an antidepressant intervention. The following assessments were performed: open‐field test (OFT), sucrose preference test (SPT), forced swim test (FST), and tail suspension test (TST). An enzyme‐linked immunosorbent assay (ELISA) was used to measure IDO1 levels and related inflammatory factors in brain tissue and peripheral blood. High‐performance liquid chromatography (HPLC) was used to measure KP metabolism‐related metabolite levels. Quantitative real‐time polymerase chain reaction (qRT‐PCR) was used to measure IDO1 and inflammation‐related factor levels. Results: LPS significantly induced depression‐like behavior in mice. Ketamine effectively alleviated this behavior, exerting an antidepressant effect and suppressing IDO1 expression, as well as the levels of inflammatory factors (IL‐1β, TNF‐α, and IL‐6). Following EA intervention, depression‐like behavior in mice with LPS‐induced depression was alleviated. EA effectively reduced peripheral and central inflammatory factor expression levels and suppressed IDO1 expression. EA alleviated depressive symptoms in mice by modulating the IDO1‐mediated KP. Conclusion: EA effectively reduced the expression of inflammatory factors, alleviated LPS‐induced depressive‐like behavior, and improved depressive symptoms by modulating the IDO1‐mediated KP.